NCT05981911Recruiting
Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
a Non-randomized, Prospective, Open-label Registry to Compare the Effectiveness and Safety of XIENCE Skypoint™ Stents Versus Other DESs in Patients With Coronary Artery Disease
Source: ClinicalTrials.gov · Last updated 2 Jan 2026
Brief summary (registry, in English)
The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 1 Aug 2023
- Start date
- 14 Dec 2023
- Primary completion date
- Jun 2026
- Lead sponsor
- Seung-Jung Park
- Diseases
- Coronary artery disease
- NCT number
- NCT05981911
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 14 Dec 2023 to the primary completion date, Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Terminal illness with life expectancy \<1 year
Other
- Patients with a mixture of other DESs
- Patients with cardiogenic shock
Who the study is looking for
- Patients ≥ 19 years old
- Patients receiving Xience-Skypoint™ stents.
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Asan Medical Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.